[1] RICHARD C,LANNER C,NARYZHNY SN,et al.The immortalizing and transforming ability of two common human papillomavirus 16 E6 variants with different prevalences in cervical cancer ［J］.Oncogene,2010,29(23):3435-3445.
[2] YEO-TEH NSL,ITO Y,JHA S.High-risk human papillomaviral oncogenes E6 and E7 target key cellular pathways to achieve oncogenesis ［J］.Int J Mol Sci,2018,19(6):1706.
[3] CLEMENTE-SOTO AF,SALAS-VIDAL E,MILAN-PACHECO C,et al.Quercetin induces G2 phase arrest and apoptosis with the activation of p53 in an E6 expressionindependent manner in HPV positive human cervical cancerderived cells ［J］.Mol Med Rep,2019,19(3):2097-2106.
[4] LI SY,HONG XL,WEI ZT,et al.Ubiquitination of the HPV oncoprotein E6 is critical for E6/E6AP-mediated p53 degradation ［J］.Front Microbiol,2019,10:2483.
[5] MARTINEZ-ZAPIEN D,RUIZ FX,POIRSON J,et al.Structure of the E6/E6AP/p53 complex required for HPV-mediated degradation of p53 ［J］.Nature,2016,529(7587):541-545.
[6] KUSS-DUERKOP SK,WESTRICH JA,PYEON D.DNA tumor virus regulation of host DNA methylation and its implications for immune evasion and oncogenesis ［J］.Viruses,2018,10(2):82.
[7] MARSH EK,DELURY CP,DAVIES NJ,et al.Mitotic control of human papillomavirus genome-containing cells is regulated by the function of the PDZ-binding motif of the E6 oncoprotein ［J］.Oncotarget,2017,8(12):19491-19506.
[8] KRANJEC C,BANKS L.A systematic analysis of human papillomavirus (HPV) E6 PDZ substrates identifies MAGI-1 as a major target of HPV type 16 (HPV-16) and HPV-18 whose loss accompanies disruption of tight junctions ［J］.J Virol,2011,85(4):1757-1764.
[9] SAIDU NEB,FILIC V,THOMAS M,et al.PDZ domain-containing protein NHERF-2 is a novel target of human papillomavirus 16 (HPV-16) and HPV-18 ［J］.J Virol,2020,94(1):e00663-19.
[10] KRANJEC C,MASSIMI P,BANKS L.Restoration of MAGI-1 expression in human papillomavirus-positive tumor cells induces cell growth arrest and apoptosis ［J］.J Virol,2014,88(13):7155-7169.
[11] YOSHIMATSU Y,NAKAHARA T,TANAKA K,et al.Roles of the PDZ-binding motif of HPV 16 E6 protein in oncogenic transformation of human cervical keratinocytes ［J］.Cancer Sci,2017,108(7):1303-1309.
[12] BOON SS,BANKS L.High-risk human papillomavirus E6 oncoproteins interact with 14-3-3zeta in a PDZ binding motif-dependent manner ［J］.J Virol,2013,87(3):1586-1595.
[13] POIRSON J,BIQUAND E,STRAUB ML,et al.Mapping the interactome of HPV E6 and E7 oncoproteins with the ubiquitin-proteasome system ［J］.FEBS J,2017,284(19):3171-3201.
[14] SARTOR MA,DOLINOY DC,JONES TR,et al.Genome-wide methylation and expression differences in HPV(+) and HPV(-) squamous cell carcinoma cell lines are consistent with divergent mechanisms of carcinogenesis ［J］.Epigenetics,2011,6(6):777-787.
[15] LECHNER M,FENTON T,WEST J,et al.Identification and functional validation of HPV-mediated hypermethylation in head and neck squamous cell carcinoma ［J］.Genome Med,2013,5(2):15.
[16] STEENBERGEN RD,ONGENAERT M,SNELLENBERG S,et al.Methylation-specific digital karyotyping of HPV16E6E7-expressing human keratinocytes identifies novel methylation events in cervical carcinogenesis ［J］.J Pathol,2013,231(1):53-62.
[17] YEUNG CLA,TSANG WP,TSANG TY,et al.HPV-16 E6 upregulation of DNMT1 through repression of tumor suppressor p53 ［J］.Oncol Rep,2010,24(6):1599-1604.
[18] D'COSTA ZJ,JOLLY C,ANDROPHY EJ,et al.Transcriptional repression of E-cadherin by human papillomavirus type 16 E6 ［J］.PLoS One,2012,7(11):e48954.
[19] CHALERTPET K,PAKDEECHAIDAN W,PATEL V,et al.Human papillomavirus type 16 E7 oncoprotein mediates CCNA1 promoter methylation ［J］.Cancer Sci,2015,106(10):1333-1340.
[20] CHUJAN S,KITKUMTHORN N,SIRIANGKUL S,et al.CCNA1 promoter methylation:a potential marker for grading Papanicolaou smear cervical squamous intraepithelial lesions ［J］.Asian Pac J Cancer Prev,2014,15(18):7971-7975.
[21] HYLAND PL,MCDADE SS,MCCLOSKEY R,et al.Evidence for alteration of EZH2,BMI1,and KDM6A and epigenetic reprogramming in human papillomavirus type 16 E6/E7-expressing keratinocytes ［J］.J Virol,2011,85(21):10999-11006.
[22] CICCHINI L,WESTRICH JA,XU T,et al.Suppression of antitumor immune responses by human papillomavirus through epigenetic downregulation of CXCL14 ［J］.mBio,2016,7(3):e00270-16.
[23] HOPPE-SEYLER K,BOSSLER F,BRAUN JA,et al.The HPV E6/E7 oncogenes:Key factors for viral carcinogenesis and therapeutic targets ［J］.Trends Microbiol,2018,26(2):158-168.
[24] FOK KL,CHUNG CM,YI SQ,et al.STK31 maintains the undifferentiated state of colon cancer cells ［J］.Carcinogenesis,2012,33(11):2044-2053.
[25] YIN FF,WANG N,BI XN,et al.Serine/threonine kinases 31(STK31) may be a novel cellular target gene for the HPV16 oncogene E7 with potential as a DNA hypomethylation biomarker in cervical cancer ［J］.Virol J,2016,13:60.
[26] SAKAMAKI JI,WILKINSON S,HAHN M,et al.Bromodomain protein BRD4 is a transcriptional repressor of autophagy and lysosomal function ［J］.Mol Cell,2017,66(4):517.
[27] SUBBAIAH VK,ZHANG Y,RAJAGOPALAN D,et al.E3 ligase EDD1/UBR5 is utilized by the HPV E6 oncogene to destabilize tumor suppressor TIP60 ［J］.Oncogene,2016,35(16):2062-2074.
[28] HSU CH,PENG KL,JHANG HC,et al.The HPV E6 oncoprotein targets histone methyltransferases for modulating specific gene transcription ［J］.Oncogene,2012,31(18):2335-2349.
[29] DING WC,HU Z,ZHU D,et al.Zinc finger nucleases targeting the human papillomavirus E7 oncogene induce E7 disruption and a transformed phenotype in HPV16/18-positive cervical cancer cells ［J］.Clin Cancer Res,2014,20(24):6495-6503.
[30] WANG L,CHEN H,WANG C,et al.Negative regulator of E2F transcription factors links cell cycle checkpoint and DNA damage repair ［J］.Proc Natl Acad Sci USA,2018,115(16):E3837-E3845.
[31] BODAGHI S,JIA R,ZHENG ZM.Human papillomavirus type 16 E2 and E6 are RNA-binding proteins and inhibit in vitro splicing of pre-mRNAs with suboptimal splice sites ［J］.Virology,2009,386(1):32-43.
[32] XU JF,FANG YF,QIN JL,et al.A transcriptomic landscape of human papillomavirus 16 E6-regulated gene expression and splicing events ［J］.FEBS Lett,2016,590(24):4594-4605.
[33] HONEGGER A,SCHILLING D,BASTIAN S,et al.Dependence of intracellular and exosomal micrornas on viral E6/E7 oncogene expression in HPV-positive tumor cells ［J］.PLoS Pathog,2015,11(3):e1004712.
[34] GU W,AN J,YE P,et al.Prediction of conserved microRNAs from skin and mucosal human papillomaviruses ［J］.Arch Virol,2011,156(7):1161-1171.
[35] LIN L,CAI QQ,ZHANG XY,et al.Two less common human microRNAs miR-875 and miR-3144 target a conserved site of E6 oncogene in most high-risk human papillomavirus subtypes ［J］.Protein Cell,2015,6(8):575-588.